29 results
Goals and limits for treatment of Hyponatremia Stratified by duration and risk of Osmotic Demyelination Syndrome
and limits for treatment ... of Hyponatremia ... Demyelination Syndrome ... Demyelination #Syndrome ... goals #limits #management
Hyponatremia - Diagnosis and Treatment
Hyponatremia is usually caused by the inability to excrete water normally.
and Treatment ... Treatment: Treatment ... demyelination syndrome ... in 100 mL boluses ... #management #nephrology
Hypertonic Saline for Treatment of Hyponatremic Encephalopathy
1) 100 ml bolus of 3% NaCl over 10 min.
Hypertonic Saline for Treatment ... of Hyponatremic ... Encephalopathy 1) 100 ml ... #management #protocol ... #hyponatremia
Hyperviscosity Syndrome - Causes and Treatment

 - Waldenstrom macroglobulinemia (most common) / Plasmapheresis 
 - Multiple
Hyperviscosity Syndrome ... - Causes and Treatment ... transformation (CML ... Hyperviscosity #Syndrome ... #Management
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #management #opportunistic
Management of Hyponatremia
Hypertonic Saline - Only indicated if patient has severe symptoms + Na < 125
Give
Management of Hyponatremia ... ECF volume • Offer ... give specific treatment ... #Management #algorithm ... #treatment #sodium
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... Inhibitors of Na+K+2Cl ... • Hyponatremia ... Tolvaptan) • Treatment ... and euvolemic hyponatremia
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Framework and Management ... - Compartment syndrome ... Hyperuricemia • Hyponatremia ... urine output: 200 ml ... Differential #Diagnosis #Management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... for effective treatment ... candida #mucosal #IDSA ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic